Join the club for FREE to access the whole archive and other member benefits.

Wearable monitor detects more cancer cells than liquid biopsy

Human trials in a few years time

01-Apr-2019

Key points from article :

Liquid biopsies look for cancer cells circulating in blood.

But they do not always show up in a single blood sample.

Cancer cells that end up in the bloodstream do not survive for long.

University of Michigan designed a wearable device to monitor blood continuously.

Collected 3.5 times more cancer cells than testing in vitro every 20 minutes.

Could replace some surgical biopsies.

Device tested in dogs - study published in Nature Communications.

Mentioned in this article:

Click on resource name for more details.

Daniel F. Hayes

Clinical Director of Breast Oncology Program at University of Michigan.

Nature Communications

Journal covering all topics in physics, chemistry, and biology

University of Michigan

Public Research university

Topics mentioned on this page:
Cancer, Diagnostics
Wearable monitor detects more cancer cells than liquid biopsy